Quanterix Corporation Deferred Federal Income Tax Expense (Benefit)
Quanterix Corporation (QTRX) reported Deferred Federal Income Tax Expense (Benefit) of -$4.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-02
- Quanterix Corporation deferred federal income tax expense (benefit) for fiscal 2025 was -$4.45M.
- Quanterix Corporation deferred federal income tax expense (benefit) for fiscal 2024 was $0.00.
- Quanterix Corporation deferred federal income tax expense (benefit) for fiscal 2023 was $0.00.
- Quanterix Corporation deferred federal income tax expense (benefit) for fiscal 2022 was -$10.00K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$4.45M 10-K · filed 2026-03-02 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2023-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2022-12-31 | -$10.00K 10-K · filed 2025-03-17 |
| 2021-12-31 | -$5.00K 10-K/A · filed 2024-12-26 |
| 2020-12-31 | $8.00K 10-K · filed 2023-03-06 |
| 2019-12-31 | $3.00K 10-K · filed 2022-03-01 |
| 2018-12-31 | $2.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |